Our results support the view of acomplex architecture of risk alleles with cumulative effects and complex genetic and epigenetic interactions, including polymorphisms in VEGFA functional pathways [23,24], that explain the variability of DS phenotypes, in particular concerning CHDs. This evidence concerns the gene VEGFA and Dravet syndrome.